Edwards Lifesciences 1st-qtr net profit falls, sales rise 5 pct

April 24 (Reuters) - Medical device maker Edwards Lifesciences Corp said on Thursday quarterly net earnings fell due to higher manufacturing costs, unfavorable foreign exchange rates and a year-earlier gain of $83.6 million related to patent litigation.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.